Lilly Slashes Revenue Forecasts For 2010 And 2011 Due To Health Care Reform

The drug maker blames changes to various government programs for revenue that will drop by hundreds of millions of dollars.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet